文献速递眼底病与葡萄膜炎

增殖性糖尿病视网膜病变患者玻璃体切除术后失访研究

LOSS TO FOLLOW-UP IN PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY AFTER PARS PLANA VITRECTOMY.
PubMed 文献 · Retina · 2026-01-01

该研究纳入2018至2024年温州医科大学附属眼视光医院1234例接受玻璃体切除术的增殖性糖尿病视网膜病变患者,失访率为54.1%。多因素分析显示糖化血红蛋白7.5%至9.0%、高血压病程≥10年、慢性肾病或尿毒症史、居住地距医院>90 km与失访正相关,而既往玻璃体腔注射史、术前就诊≥3次及硅油填充与失访负相关。

要点

  • 增殖性糖尿病视网膜病变玻璃体切除术后失访率高达54.1%。
  • 糖化血红蛋白7.5%至9.0%、高血压≥10年、肾病/尿毒症、距离>90 km增加失访风险。
  • 术前玻璃体腔注射、术前就诊≥3次及硅油填充降低失访风险。

核心结论

  • 研究识别了增殖性糖尿病视网膜病变患者玻璃体切除术后失访的多个相关因素,需进一步研究确认以减少术后并发症风险。

研究设计与样本

  • 回顾性收集2018至2024年温州医科大学附属眼视光医院玻璃体视网膜外科1234例接受玻璃体切除术的增殖性糖尿病视网膜病变患者信息。
  • 失访定义为术后6个月内至少1个间隔超过3个月无后续就诊,且6个月至1年无任何就诊记录。

主要发现

  • 1234例患者中668例(54.1%)失访。
  • 多因素分析显示术前糖化血红蛋白7.5%至9.0%(OR=1.88,P=0.018)与失访正相关。
  • 高血压病程≥10年(OR=1.61,P=0.048)、慢性肾病或尿毒症史(OR=3.55,P=0.005)、居住地邮编距医院>90 km(OR=2.03,P=0.008)与失访正相关。
  • 研究眼既往玻璃体腔注射史(OR=0.67,P=0.041)、术前就诊≥3次(OR=0.62,P=0.011)、玻璃体切除术中使用硅油填充(OR=0.14,P<0.001)与失访负相关。

关键数值与推荐

  • 失访定义:术后6个月内至少1个间隔超过3个月无后续就诊,且6个月至1年无任何就诊记录。
  • 术前糖化血红蛋白7.5%至9.0%的OR为1.88(P=0.018)。
  • 高血压病程≥10年的OR为1.61(P=0.048)。
  • 慢性肾病或尿毒症史的OR为3.55(P=0.005)。
  • 居住地邮编距医院>90 km的OR为2.03(P=0.008)。

临床怎么用

  • 对糖化血红蛋白7.5%至9.0%、高血压≥10年、慢性肾病或尿毒症史、居住地距医院>90 km的患者应加强术后随访管理。
  • 既往玻璃体腔注射史、术前就诊≥3次及硅油填充可能提示较低失访风险,可据此识别高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to determine the risk factors of loss to follow-up (LTFU) in patients with proliferative diabetic retinopathy (PDR) undergoing pars plana vitrectomy (PPV) therapy. METHODS: Information of patients with PDR undergoing PPV at the Department of Vitreoretinal Surgery, the Eye Hospital of Wenzhou Medical University, between 2018 and 2024 was collected. LTFU was defined as at least 1 interval exceeding 3 months without a subsequent visit in the first 6 months after PPV and not having any provider encounters documented from 6 months to 1 year. RESULTS: Among 1,234 patients with PDR after PPV, 668 (54.1%) were LTFU. Risk factors positively associated with LTFU on multivariable analysis included preoperative hemoglobin A1c 7.5% to 9.0% (odds ratio [OR], 1.88; P = 0.018), a duration of hypertension ≥10 years (OR, 1.61; P = 0.048), a history of chronic kidney disease or uremia (OR, 3.55; P = 0.005), and distance between home postal code and hospital >90 km (OR, 2.03; P = 0.008). Protective factors against LTFU included a history of intravitreal injection(s) in the study eye (OR, 0.67; P = 0.041), ≥3 preoperative visits (OR, 0.62; P = 0.011), and the use of silicone oil tamponade during vitrectomy (OR, 0.14; P < 0.001). CONCLUSION: The authors identified multiple factors associated with LTFU and warrant further study to confirm their results to minimize the risk of potential complications during the postoperative period.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Dai Z, Fan W, Yao Q, et al. LOSS TO FOLLOW-UP IN PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY AFTER PARS PLANA VITRECTOMY. Retina. 2026. PMID: 41983912. doi:10.1097/IAE.0000000000004859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。